Patricia B Pavlinac

Biographic Data

ID6652875
NAMEPatricia B Pavlinac
GIVEN NAMESPatricia B
FAMILY NAMEPavlinac
SIGNATUREPAVLINAC P B
AFFILIATIONSUniversity of Washington
ORCID0000-0002-0051-9131
VERIFIEDYes
TOTAL WORKS11
TOTAL CITATIONS4
AUTHOR COUNT11
EDITOR COUNT0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2026
H-INDEX1

  • Exploring risk factors associated with catastrophic health expenditure on diarrhea management in Karachi, Pakistan, 2022-2024

    Open AccessNaveed Ahmed, Mohammad Tahir Yousafzai et al.ARTICLEPLOS Global Public Health2026

    Catastrophic health expenditure (CHE) is a situation where a household’s out-of-pocket medical payments are excessively high relative to its income, potentially leading to impoverishment. This study explores the risk factors associated with CHE in the management of diarrhea among children enrolled in Enterics for Global Health (EFGH) facilities in Karachi, Pakistan. We conducted a secondary analysis of data from 1,400 children presenting with dia…

  • Frequency and correlates of non-receipt of age-appropriate vaccination among children aged 6-35 months with medically attended diarrhea

    Open AccessCaren Oreso, Billy Ogwel et al.ARTICLEPLOS Global Public Health2026

    Complete childhood immunization protects children from long-term health complications and disabilities caused by vaccine-preventable diseases. Enterics for Global Health (EFGH)- Shigella surveillance was a two-year study measuring incidence rates and consequences of Shigella among children aged 6–35 months in seven sites located in Asia, Latin America and Africa. Here, we estimated the prevalence and factors associated with non-receipt of age-app…

  • Scientific writing capacity building with early career researchers during study implementation

    Open AccessSonia I Rao, Beth A Tippett Barr et al.ARTICLEPLOS Global Public Health2026

  • Temporal patterns and risk factors of diarrheal comorbidity among children aged < 5 years in rural western Kenya

    Open AccessBilly Ogwel, Bryan O Nyawanda et al.ARTICLEPLOS Global Public Health2026

    Sub-Saharan Africa bears the highest burden of diarrhea, often complicated by comorbidities that delay diagnosis, hinder treatment, and worsen outcomes. As the epidemiology of diarrheal disease evolves, understanding comorbidity patterns is critical for effective public health responses. We examined the temporal patterns and risk factors of diarrheal comorbidity in Kenyan children aged Shigella surveillance study (2022–2024). The outcome was como…

  • Risk factors associated with Shigella diarrhea in 6–35-month-olds

    Open AccessVitumbiko P Yagontha Munthali, Olivia Schultes et al.ARTICLEPLOS Global Public Health2026

    Diarrhea due to Shigella causes 60,000 deaths annually among children under five in low- and middle-income countries. This Enterics for Global Health sub-study examined host, clinical, and environmental factors linked to Shigella -attributable diarrhea in Malawian children and assessed seasonal variations. Data from 1,399 children aged 6–35 months presenting with diarrhea at a health centre in Blantyre, Southern Malawi from August 3, 2022, throug…

  • Effect of azithromycin on post-discharge growth in Kenyan children

    Open AccessHannah E Atlas, Polycarp Mogeni et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: Children discharged following hospitalisation for acute illnesses in low- and middle-income settings are at increased risk of poor growth, particularly linear growth faltering. We aimed to determine the effect of azithromycin administered at hospital discharge on post-discharge growth. METHODS: Using data from the Toto Bora Trial (NCT02414399), a double-blind, placebo-controlled randomised trial of a 5-day course of azithromycin in …

  • Is rotavirus aetiology in young children with acute diarrhoea associated with sociodemographic and clinical factors, including rotavirus vaccination status? A secondary cross-sectional analysis of the…

    Open AccessSarah Somji, Christopher R Sudfeld et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: One of the leading causes of global child mortality continues to be diarrhoea where rotavirus contributed to about 24% of deaths among all diarrhoeal deaths, mostly in low-income and middle-income countries. Rotavirus vaccination programmes have contributed to the reduction of mortality from 24% to 19% in rotavirus infections among hospitalised children, but the burden of rotaviral diarrhoea remains high, especially in settings with…

  • The diagnosis and management of dehydration in children with wasting or nutritional edema

    Open AccessAdino Tesfahun Tsegaye, Patricia B Pavlinac et al.ARTICLEPLOS Global Public Health2023

    Dehydration is a major cause of death among children with wasting and diarrhea. We reviewed the evidence for the identification and management of dehydration among these children. Two systematic reviews were conducted to assess 1) the diagnostic performance of clinical signs or algorithms intended to measure dehydration, and 2) the efficacy and safety of low-osmolarity ORS versus ReSoMal on mortality, treatment failure, time to full rehydration, …

  • Derivation and external validation of a clinical prognostic model identifying children at risk of death following presentation for diarrheal care

    Open AccessSharia M Ahmed, Ben J Brintz et al.ARTICLEPLOS Global Public Health2023

    Diarrhea continues to be a leading cause of death for children under-five. Amongst children treated for acute diarrhea, mortality risk remains elevated during and after acute medical management. Identification of those at highest risk would enable better targeting of interventions, but available prognostic tools lack validation. We used clinical and demographic data from the Global Enteric Multicenter Study (GEMS) to build clinical prognostic mod…

  • Birth size and early pneumonia predict linear growth among HIV‐exposed uninfected infants

    Open AccessE Deichsel, Patricia B Pavlinac et al.ARTICLEMaternal and Child Nutrition2019

    Stunting remains a global health priority, particularly in sub-Saharan Africa. Identifying determinants of linear growth in HIV-exposed uninfected (HEU) infants can inform interventions to prevent stunting in this vulnerable population. HIV-infected mothers and their uninfected infants were followed monthly from pregnancy to 12-month post-partum in Nairobi, Kenya. Mixed-effects models estimated the change in length-for-age z-score (LAZ) from birt…

  • Three Years after Legalization of Nonprescription Pharmacy Syringe Sales in California

    Open AccessRICHARD S GARFEIN, Thomas J Stopka et al.ARTICLEJournal of Urban Health2010Cited by: 4References: 4

    In January 2005, passage of California Senate Bill 1159 enabled California's county or city governments to establish disease prevention demonstration projects (DPDPs) through which pharmacies could subsequently register to legally sell up to 10 syringes to adults without a prescription. California's 61 local health jurisdictions (LHJs) were surveyed annually in 2005-2007 to monitor the progress of DPDP implementation and assess program coverage, …